June

June 29, 2019

Partial or Sleeve gastrectomy functions as a curative therapy for autoimmune (Type I) diabetes (TIDM):  Partial/Sleeve gastrectomy promotes the expression of PD-L1, attenuates the expression of tumor suppressor TXNIP, augments Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 30/June/2019, 12.43 am

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical […]
June 29, 2019

Live longer by consuming black pepper seeds or oil:  Piperine-based Lifespan extension therapy:  Piperine, derived from black pepper/Pepper nigrum,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian lifespan by regulating the expression of its target genes, 29/June/2019, 11.17 pm

What they say: A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal […]
June 28, 2019

Consume plenty of black cumin seeds to stay free of cognitive dysfunction and neurodegeneration: Thymoquinone (TQ)-based regenerative therapy for improving cognitive deficits in aged individuals: Thymoquinone (TQ), isolated from black cumin (Nigella Sativa) seeds and oil,  decreases vascular cell adhesion molecule 1 (VCAM 1), inhibits microglia activity, increases hippocampal neural precursor activity, ameliorates cognition, & attenuates age-related neurodegeneration, through up regulation of its target genes, 28/June/2019, 7.50 am

Introduction: What they say A study from the Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA, VA Palo Alto Health […]
June 27, 2019

Curing autoimmune diabetes  (TIDM) with HDAC (Histone deacetylase) inhibitors: Vorinostat-based therapy for autoimmune diabetes: Vorinostat (brand name: Zolinza and others), a histone deacetylase inhibitor used to treat cutaneous T-cell lymphoma (CTCL), increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 27/June/2019, 11.54 pm

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and […]